Nasdaq
CBIO
Crescent Biopharma, Inc.
- Health Care
- Listed 2014
- 1 day
- +4.2%
- 1 month
- −3.5%
- 1 year
- +49.4%
$16.43 · Mkt cap $610M
At the 6 Aug 2026 close
Nasdaq
Crescent Biopharma, Inc.
$16.43 · Mkt cap $610M
At the 6 Aug 2026 close
Crescent Biopharma, Inc. trades under the ticker CBIO on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2014. Its market capitalisation is $610M. The last closing price was $16.43, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +49.4%, and −3.5% over the past month. Returns are price returns and exclude dividends.
This page exists because CBIO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.